Muscular Dystrophy Canada Funds Projects on Newborn SMA Screening

Muscular Dystrophy Canada Funds Projects on Newborn SMA Screening

301277

Muscular Dystrophy Canada Funds Projects on Newborn SMA Screening

To better understand and address barriers to the implementation of newborn screening across Canada for spinal muscular atrophy (SMA), Muscular Dystrophy Canada (MDC) has awarded more than $700,000 to projects in three provinces. This is the first round of awards to come from a collaboration between MDC and Novartis Pharmaceuticals Canada that began last year. Ultimately, $2 million will be invested in the multi-year initiative, which also will include ongoing support for the production of…

You must be logged in to read/download the full post.